Costanzo Costamagna
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Targeting a novel metabolic vulnerability of non-small cell lung cancer to fatty acid oxidation surmounts chemoresistance.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: December 13, 2025
Two are better than one: A case study of the biferrocenyl-thymidine "click" conjugate biFcT as novel ferroptosis-inducing agent in lung cancer cells.
Journal: Bioorganic chemistry
Published: March 23, 2025
Blood-brain barrier permeability increases with the differentiation of glioblastoma cells in vitro.
Journal: Fluids and barriers of the CNS
Published: December 31, 2023
Use of Enzymatically Activated Carbon Monoxide Donors for Sensitizing Drug-Resistant Tumor Cells.
Journal: International journal of molecular sciences
Published: June 01, 2023
Corrigendum to 'Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein' [Pharmacol. Res. 175 (2022) 105975].
Journal: Pharmacological research
Published: March 03, 2023
Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 23, 2022
Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein.
Journal: Pharmacological research
Published: August 18, 2021
Plant-Derived Trans-β-Caryophyllene Boosts Glucose Metabolism and ATP Synthesis in Skeletal Muscle Cells through Cannabinoid Type 2 Receptor Stimulation.
Journal: Nutrients
Published: February 02, 2021
MRP1-Collateral Sensitizers as a Novel Therapeutic Approach in Resistant Cancer Therapy: An In Vitro and In Vivo Study in Lung Resistant Tumor.
Journal: International journal of molecular sciences
Published: March 30, 2020
Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells.
Journal: Molecular pharmaceutics
Published: July 03, 2019
New Tetrahydroisoquinoline Derivatives Overcome Pgp Activity in Brain-Blood Barrier and Glioblastoma Multiforme in Vitro.
Journal: Molecules (Basel, Switzerland)
Published: May 13, 2018
Last Updated: 09/26/2026